Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study

Journal of Cardiovascular Pharmacology · Published 2026-04-08 · DOI 10.1097/fjc.0000000000001824

Authors being retrieved — see the publisher record. https://doi.org/10.1097/fjc.0000000000001824

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Melissa officinalis extract attenuates gamma radiation-induced cardiac injury in rats: An integrated bioinformatics and experimental study · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Magnitude of blood pressure reduction in response to levosimendan infusion independently predicts in-hospital mortality in patients with acute heart failure · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Aspirin in primary prevention: a case for selective use · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Imipramine Can Block Human Cardiac H1-Histamine Receptors · Journal of Cardiovascular Pharmacology · 2026 · Same journal
The Cardiac Sarcomere: From development of heritable cardiomyopathies to gene and precision therapies · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Human Histamine-1 Receptor Antagonism by Imipramine: Bridging Experimental Models and Clinical Cardiotoxicity · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Safety and effectiveness of somatostatin and analogues on chest tube output after coronary artery bypass grafting: A scoping review · Journal of Cardiovascular Pharmacology · 2026 · Same journal
Reversal of the Anticoagulant Effect of Milvexian by 4-Factor PCC and rFVIIa in Healthy Participants: a Two-Part, Randomized, Crossover Study · Journal of Cardiovascular Pharmacology · 2026 · Same journal